Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression
What this study shows
Genetically reduced mTOR increases mouse lifespan with tissue-specific slowing of aging.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse (mTOR hypomorph)); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Mouse (mTOR hypomorph) |
| Journal | Cell reports |
| Year | 2013 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1016/j.celrep.2013.07.030 · PMID 23994476 · Free full text (PMC3784301) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic (mTOR hypomorph, ~25% expression) |
| Target | mTORC1 & mTORC2 |
| Model | Mouse (mTOR hypomorph) |
| Effect | Genetic reduction of mTOR extends median lifespan ~20% with segmental, tissue-specific slowing of aging |
| Dose | mTOR protein reduced to approximately 25% of wild type levels |
| Sample size | males: n=17 (mTOR Δ/Δ), n=10 (WT); females: n=26 (mTOR Δ/Δ), n=24 (WT); combined: n=43 (mTOR Δ/Δ), n=34 (WT) |
| Effect size | Median survival increased by 22% for males (p=0.02) and 19% for females (p=0.047); overall median survival 30.3 months for mTOR Δ/Δ vs 26.2 months for WT (p=0.0057) |
| Limitations | Higher euthanasia rate for mTOR Δ/Δ mice due to severe infections (37% vs 17% WT, p<0.01); exacerbated age-dependent decrease in trabecular bone volume and increased age-dependent infections (mouth, eye, skin) in mTOR Δ/Δ mice |
In the Atlas
Related topics
Open questions that cite this study
- Cited as supporting evidence for the open question Does the larger rapamycin benefit in female mice survive equal drug exposure, and is it set by hormones or by chromosomes?.
More studies on this topic
- mTOR signaling in growth control and disease (2012)
- mTOR at the nexus of nutrition, growth, ageing and disease (2020)
- Lysosomal mTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy (2015)
- mTOR substrate phosphorylation in growth control (2022)
Was this page useful?
Thank you. Your answer was counted anonymously.